26.2 F
Park Forest
Wednesday, November 30, 2022
The Free Press Isn't Free. Like what you see? Please subscribe.

Study: Administration Of Non-Psychotropic Cannabinoid Halts Colon Cancer Progression

Study: Administration Of Non-Psychotropic Cannabinoid Halts Colon Cancer Progression

Naples, Italy–(ENEWSPF)–October 12, 2014.  The administration of the non-psychotropic cannabinoid cannabigerol (CBG) possesses potent anti-colon cancer activities and inhibits cancerous tumor growth, according to preclinical data published online ahead of print in the journal Carcinogenesis. Colorectal cancer is the third most common cancer in men and the second most common cancer in women worldwide.

Italian researchers at the University of Naples assessed the effects of CBG on colon tumorigenesis in vitro and in vivo. Investigators reported that the compound promoted apoptosis (cancer cell death) and reduced cell growth in colorectal cancer cells. CBG dosing also inhibited an experimental model of colorectal tumor growth in animals.

Authors concluded: “Our data show that the non-psychotropic cannabis ingredient cannabigerol inhibits the growth of colorectal cancer cells … and hinders the development and growth of colon carcinogenesis in vivo. … [W]e hypothesize that CBG may be a promising anti-colorectal cancer therapeutic agent, both for prevention and as a curative medicine.”

Cannabinoids and endocannabinoids have been shown both independently and adjunctively to possess anti-cancer activity in preclinical models, halting the proliferation of glioma cells, breast carcinoma, lung carcinoma, and lymphoma, among other cancer cell lines.

Full text of the study, “Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a cannabis-derived non-psychotropic cannabinoid,” appears in Carcinogenesis.

Source:  http://norml.org


Recent Articles

Stay Connected


Local Advertisers



Park Forest
clear sky
26.2 ° F
27 °
24.7 °
61 %
0 %
33 °
47 °
51 °
37 °
33 °

About Google Ads

The Google-supplied ads that appear on this website are not reviewed ahead of time and differ for each visitor. If anything offensive, inappropriate, or otherwise unwholesome appears, please notify us so we can take steps to block that specific advertiser. Email the URL or advertiser name to [email protected].